The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The locus ceruleus norepinephrine system: Functional organization and potential clinical significance
Abstract
IL-9–producing Th cells, termed Th9 cells, contribute to immunity against parasites and cancers but have detrimental roles in allergic disease and colitis. Th9 cells differentiate in response to IL-4 and TGF-β, but these signals are insufficient to drive Th9 differentiation in the absence of IL-2. IL-2–induced STAT5 activation is required for chromatin accessibility within Il9 enhancer and promoter regions and directly transactivates the Il9 locus. STAT5 also suppresses gene expression during Th9 cell development, but these roles are less well defined. In this study, we demonstrate that human allergy-associated Th9 cells exhibited a signature of STAT5-mediated gene repression that is associated with the silencing of a Th17-like transcriptional signature. In murine Th9 cell differentiation, blockade of IL-2/STAT5 signaling induced the expression of IL-17 and the Th17-associated transcription factor Rorγt. However, IL-2–deprived Th9 cells did not exhibit a significant Th17- or STAT3-associated transcriptional signature. Consistent with these observations, differentiation of IL-17–producing cells under these conditions was STAT3-independent but did require Rorγt and BATF. Furthermore, ectopic expression of Rorγt and BATF partially rescued IL-17 production in STAT3-deficient Th17 cells, highlighting the importance of these factors in this process. Although STAT3 was not required for the differentiation of IL-17–producing cells under IL-2–deprived Th9 conditions, their prolonged survival was STAT3-dependent, potentially explaining why STAT3-independent IL-17 production is not commonly observed in vivo. Together, our data suggest that IL-2/STAT5 signaling plays an important role in controlling the balance of a Th9 versus a Th17-like differentiation program in vitro and in allergic disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NE modulates multiple functions, including arousal, attention, stress, and learning and memory”
From The medial prefrontal cortex - hippocampus circuit that integrates information of object, place and time to construct episodic memory in rodents: Behavioral, anatomical and neurochemical properties (2020) · cites this paper as Benarroch, 2009
In the citing paper
“The locus coeruleus located in the brainstem is a cluster of adrenergic neurons that release NE across the central nervous system.”
From The medial prefrontal cortex - hippocampus circuit that integrates information of object, place and time to construct episodic memory in rodents: Behavioral, anatomical and neurochemical properties (2020) · cites this paper as Benarroch, 2009
Citations
Cites
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
The reorienting system of the human brain: from environment to theory of mind
Corbetta, M., Patel, G., & Shulman, G. L. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.017 · Cited by 3,889
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529
The locus coeruleus and noradrenergic modulation of cognition
Sara, S. J. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2573 · Cited by 1,848
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,003
Network reset: a simplified overarching theory of locus coeruleus noradrenaline function
Bouret, S., & Sara, S. J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.09.002 · Cited by 862
Adrenergic pharmacology and cognition: Focus on the prefrontal cortex
Ramos, B. P., & Arnsten, A. F. T. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.006 · Cited by 641
Fuller, P. M., Gooley, J. J., & Saper, C. B. (2006) · Journal of Biological Rhythms · doi:10.1177/0748730406294627 · Cited by 636
Convergent regulation of locus coeruleus activity as an adaptive response to stress
Valentino, R. J., & Van Bockstaele, E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.062 · Cited by 569
Disease‐specific patterns of locus coeruleus cell loss
German, D. C., Manaye, K. F., White, C. L., Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N., & Mann, D. M. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320510 · Cited by 512
Grudzien, A., Shaw, P., Weintraub, S., Bigio, E., Mash, D. C., & Mesulam, M. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.007 · Cited by 396
Noradrenergic modulation of arousal
Berridge, C. W. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.10.013 · Cited by 368
Phasic norepinephrine: A neural interrupt signal for unexpected events
Dayan, P., & Yu, A. J. (2006) · Network Computation in Neural Systems · doi:10.1080/09548980601004024 · Cited by 319
Heneka, M. T., Ramanathan, M., Jacobs, A. H., Dumitrescu-Ozimek, L., Bilkei-Gorzo, A., Debeir, T., Sastre, M., Galldiks, N., Zimmer, A., Hoehn, M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4236-05.2006 · Cited by 305
Locus Coeruleus α-Adrenergic–Mediated Activation of Cortical Astrocytes In Vivo
Bekar, L. K., He, W., & Nedergaard, M. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn040 · Cited by 301
Norepinephrine: The redheaded stepchild of Parkinson's disease
Rommelfanger, K. S., & Weinshenker, D. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.036 · Cited by 261
Drug enhancement of memory consolidation: historical perspective and neurobiological implications
McGaugh, J. L., & Roozendaal, B. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1285-6 · Cited by 250
Szot, P., White, S. S., Greenup, J. L., Leverenz, J. B., Peskind, E. R., & Raskind, M. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4265-05.2006 · Cited by 249
The Locus Ceruleus Is Involved in the Successful Retrieval of Emotional Memories in Humans
Sterpenich, V., D'Argembeau, A., Desseilles, M., Balteau, E., Albouy, G., Vandewalle, G., Degueldre, C., Luxen, A., Collette, F., & Maquet, P. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1001-06.2006 · Cited by 245
The pontine REM switch: past and present
Fuller, P. M., Saper, C. B., & Lu, J. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.140160 · Cited by 221
Modulators in concert for cognition: Modulator interactions in the prefrontal cortex
Briand, L. A., Gritton, H., Howe, W. M., Young, D. A., & Sarter, M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.06.007 · Cited by 216
Kalinin, S., Gavrilyuk, V., Polak, P. E., Vasser, R., Zhao, J. J., Heneka, M. T., & Feinstein, D. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.003 · Cited by 202
Functional Consequences of Locus Coeruleus Degeneration in Alzheimers Disease
Weinshenker, D. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533286 · Cited by 180
Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease
Rascol, O., Arnulf, I., Paul, H. P., Brefel‐Courbon, C., Vidailhet, M., Thalamas, C., Bonnet, A. M., Descombes, S., Bejjani, B.-P. W., Fabre, N., et al. (2001) · Movement Disorders · doi:10.1002/mds.1143 · Cited by 149
Noradrenoceptor antagonism with idazoxan improves l-dopa-induced dyskinesias in MPTP monkeys
Grondin, R., Tahar, A. H., Doan, V. D., Ladure, P., & Bédard, P. J. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900167 · Cited by 91
Haglund, M., Sjöbeck, M., & Englund, E. M. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00725.x · Cited by 81
Waterhouse, B. D., Devilbiss, D. M., Fleischer, D., Sessler, F. M., & Simpson, K. L. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60856-x · Cited by 33
Neuropharmacological Treatment of Mental Dysfunction in Parkinson’s Disease
McNamara, P., & Durso, R. (2006) · Behavioural Neurology · doi:10.1155/2006/138263 · Cited by 17
Chemically Coded Transmitter Systems
Bloom, F. E. (1979) · Progress in brain research · doi:10.1016/s0079-6123(08)61300-x · Cited by 7
Research works printed but not linked: 1
- McCormick DA. Neurotransmitter actions in the thalamus and cerebral cortex. J Clin Neurophysiol 1992;9:212–223.
Cited by
Sorted by citations
The pathological process underlying Alzheimer’s disease in individuals under thirty
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0789-4 · Cited by 812
The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease
Braak, H., & Del Tredici, K. (2015) · Brain · doi:10.1093/brain/awv236 · Cited by 540
Sleep and anxiety: From mechanisms to interventions
Chellappa, S. L., & Aeschbach, D. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101583 · Cited by 509
Review: Sporadic Parkinson's disease: development and distribution ofα‐synuclein pathology
Tredici, K. D., & Braak, H. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12298 · Cited by 416
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Betts, M. J., Kirilina, E. P., Otaduy, M. C. G., Ivanov, D., Acosta‐Cabronero, J., Callaghan, M. F., Lambert, C., Cárdenas‐Blanco, A., Pine, K., Passamonti, L., et al. (2019) · Brain · doi:10.1093/brain/awz193 · Cited by 367
Metadata
- Authors
- Benarroch, E. E.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Benarroch, Eduardo E.
- Venue
- Neurology
- Published
- 2009-11-17
- Volume
- 73
- Issue
- 20
- Pages
- 1699-1704
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1969610953
- Cited by
- 317
- References
- 29
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 17 · 2023: 32 · 2022: 23 · 2021: 24 · 2020: 32 · 2019: 22 · 2018: 32 · 2017: 17 · 2016: 16 · 2015: 13 · 2014: 19 · 2013: 9 · 2012: 13
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- locus coeruleus, norepinephrine, noradrenergic neurons, noradrenergic neurotransmission
- MeSH terms
- Alzheimer Disease, Animals, Arousal, Attention, Brain, Humans, Locus Coeruleus, Memory, Neural Pathways, Neurons, Norepinephrine, Parkinson Disease, Stress, Psychological, Prosencephalon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
